Axitinib is a selective inhibitor of vascular endothelial growth factor (VEGFR) receptors. It is indicated in the treatment of renal cell cancer when other alternative therapies have failed. Let's learn about the uses and notes when using Axitinib through the article below.

Siêu âm trong chẩn đoán ung thư tế bào thận có thể quan sát được vị trí, kích thước ung thư tế bào thận và điều trị kịp thời khi khối u chưa có triệu chứng lâm sàng.

Renal cell carcinoma is one of the most common types of urinary tract cancer, often seen in people over the age of 50. This is a dangerous cancer that can cause serious complications for the patient, even lead to death if not treated promptly.